NCT05034601 is a NA clinical trial of ESPB group in Nerve Block, sponsored by West China Hospital.

Who is sponsoring NCT05034601?

NCT05034601 is sponsored by West China Hospital.

What drugs are being tested in NCT05034601?

Interventions in NCT05034601: ESPB group, TPVB group.

What condition does NCT05034601 study?

NCT05034601 studies Nerve Block, Analgesia, Pectus Excavatum.

Is NCT05034601 still recruiting?

NCT05034601 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT05034601

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure

Completed NA Last updated 18 November 2023

What this trial tests

NA trial testing ESPB group in Nerve Block in 68 participants. Completed in 23 March 2023.

Timeline

25 September 2021

Primary endpoint
23 March 2023

23 March 2023

Quick facts

Lead sponsor	West China Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	68
Start date	25 September 2021
Primary completion	23 March 2023
Estimated completion	23 March 2023
Sites	1 location across China

Drugs / interventions tested

ESPB group
TPVB group

Conditions studied

Nerve Block — all drugs for Nerve Block →
Analgesia — all drugs for Analgesia →
Pectus Excavatum — all drugs for Pectus Excavatum →

Sponsor

West China Hospital

Who can join

Adults 4 to 18, any sex, with Nerve Block or Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized double-blind non-inferiority trial designed to test the hypothesis that erector spinae plane block (ESPB) is non-inferior to thoracic paravertebral block (TPVB) in postoperative pain control after pectus excavatum repair.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of erector spinae plane and paravertebral nerve blocks for postoperative analgesia in children after the Nuss procedure: study protocol for a randomized controlled non-inferiority clinical trial.
Xu M, Zhang G, Gong J, Yang J. · · 2022 · cited 7× · PMID 35164831 · DOI 10.1186/s13063-022-06044-y

Verify or expand the search:

Other trials of ESPB group

Trials testing the same drug.

NCT06598852 — To Compare the Analgesic Effects of Different Nerve Block Analgesia Methods in Thoracoscopic Surgery · NA · recruiting
NCT06836635 — Postoperative Analgesia After Video-Assisted Thoracoscopic Surgery · NA · completed
NCT04837742 — The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy · NA · completed
NCT04039321 — Erector Spina Plane Block in Laparoscopic Sleeve Gastrectomy Surgery · NA · completed

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

NCT07509866 — Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal · NA · recruiting
NCT07346885 — Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery · NA · active not recruiting
NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT07510269 — Investigation of the Effects of Serratus Posterior Superior Intercostal Plane Block and Serratus Anterior Plane Block on · NA · recruiting

Other West China Hospital trials

Trials by the same sponsor.

NCT07583654 — Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
NCT07583914 — Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors · Phase 1 · not yet recruiting
NCT07492914 — Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma · Phase 2 · recruiting
NCT07507097 — Study on the Optimal Head Position for Patients With Severe Acute Ischemic Stroke · NA · not yet recruiting
NCT07472933 — Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05034601 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by West China Hospital
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05034601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing